| Literature DB >> 26161545 |
Edward S Dove1, I Ömer Barlas2, Kean Birch3, Catharina Boehme4, Alexander Borda-Rodriguez5,6, William M Byne7, Florence Chaverneff8, Yavuz Coşkun9, Marja-Liisa Dahl10, Türkay Dereli11, Shyam Diwakar12, Levent Elbeyli13, Laszlo Endrenyi14, Belgin Eroğlu-Kesim15, Lynnette R Ferguson16, Kıvanç Güngör17, Ulvi Gürsoy18, Nezih Hekim19, Farah Huzair20, Kabeer Kaushik21, Ilona Kickbusch22, Olcay Kıroğlu23, Eugene Kolker24,25,26,27, Eija Könönen18, Biaoyang Lin28,29, Adrian Llerena30, Faruk Malhan31, Bipin Nair12, George P Patrinos32, Semra Şardaş33, Özlem Sert34, Sanjeeva Srivastava35, Lotte M G Steuten36,37, Cengiz Toraman38, Effy Vayena39, Wei Wang40,41, Louise Warnich42, Vural Özdemir9,11,12,26,38.
Abstract
Diagnostics spanning a wide range of new biotechnologies, including proteomics, metabolomics, and nanotechnology, are emerging as companion tests to innovative medicines. In this Opinion, we present the rationale for promulgating an "Essential Diagnostics List." Additionally, we explain the ways in which adopting a vision for "Health in All Policies" could link essential diagnostics with robust and timely societal outcomes such as sustainable development, human rights, gender parity, and alleviation of poverty. We do so in three ways. First, we propose the need for a new, "see through" taxonomy for knowledge-based innovation as we transition from the material industries (e.g., textiles, plastic, cement, glass) dominant in the 20(th) century to the anticipated knowledge industry of the 21st century. If knowledge is the currency of the present century, then it is sensible to adopt an approach that thoroughly examines scientific knowledge, starting with the production aims, methods, quality, distribution, access, and the ends it purports to serve. Second, we explain that this knowledge trajectory focus on innovation is crucial and applicable across all sectors, including public, private, or public-private partnerships, as it underscores the fact that scientific knowledge is a co-product of technology, human values, and social systems. By making the value systems embedded in scientific design and knowledge co-production transparent, we all stand to benefit from sustainable and transparent science. Third, we appeal to the global health community to consider the necessary qualities of good governance for 21st century organizations that will embark on developing essential diagnostics. These have importance not only for science and knowledge-based innovation, but also for the ways in which we can build open, healthy, and peaceful civil societies today and for future generations.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26161545 DOI: 10.1089/omi.2015.0075
Source DB: PubMed Journal: OMICS ISSN: 1536-2310